Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 469281 - 469300 out of 476556 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EA05) ponatinib (adm: O) | ICLUSIG 45MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid;Leukemia, Lymphoid | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 40MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 40MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EB03) afatinib (adm: O) | GILOTRIF 20MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EB03) afatinib (adm: O) | GILOTRIF 20MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EB03) afatinib (adm: O) | GILOTRIF 30MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EB03) afatinib (adm: O) | GILOTRIF 30MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EB03) afatinib (adm: O) | GILOTRIF 40MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EB03) afatinib (adm: O) | GILOTRIF 40MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 15MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Pfizer,Inc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 15MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Pfizer,Inc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 30MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Pfizer,Inc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 30MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Pfizer,Inc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 45MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Pfizer,Inc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 45MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Pfizer,Inc. |
| USA | (L01EC) b-raf serine-threonine kinase (braf) inhibitors | OJEMDA 100MG TAB,PKT,4 | 16 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | DayOneBiopharmaceuticals,Inc. |
| USA | (L01EC) b-raf serine-threonine kinase (braf) inhibitors | OJEMDA 100MG TAB,PKT,5 | 20 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | DayOneBiopharmaceuticals,Inc. |
| USA | (L01EC) b-raf serine-threonine kinase (braf) inhibitors | OJEMDA 100MG TAB,PKT,6 | 24 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | DayOneBiopharmaceuticals,Inc. |
Pages
